New Study Reveals 340B Program Significantly Larger Than Previously Understood

• Amanda Bridges
• September 15, 2015
• News

A new study released today from the Community Oncology Alliance (COA) finds that the 340B drug discount program is significantly larger than previous estimates have shown. Much of the growth is concentrated in oncology drugs for which 340B hospitals cost Medicare and beneficiaries more than community oncology clinics.

[su_button url=”http://app.streamsend.com/c/24877027/900393/vmfceBi/SWYY?redirect_to=http%3A%2F%2Fwww.thestreet.com%2Fstory%2F13288335%2F1%2Fnew-study-reveals-340b-program-significantly-larger-than-previously-understood.html” target=”blank” style=”flat” background=”#f70032″ color=”#ffffff” size=”5″ center=”yes” icon=”icon: arrow-circle-o-right”]Read Full Article Here[/su_button]